THE INFLUENCE OF TUMOR TEMPERATURE ON ISCHEMIA-INDUCED CELL-DEATH - POTENTIAL IMPLICATIONS FOR THE EVALUATION OF VASCULAR MEDIATED THERAPIES

被引:24
作者
CHAPLIN, DJ
HORSMAN, MR
机构
[1] BRITISH COLUMBIA CANC RES CTR, MED BIOPHYS UNIT, VANCOUVER V5Z 1L3, BC, CANADA
[2] DANISH CANC SOC, DEPT EXPTL CLIN ONCOL, DK-8000 AARHUS, DENMARK
基金
英国医学研究理事会;
关键词
ISCHEMIA; TUMOR CELL SURVIVAL; GROWTH DELAY; HYPOXIA; TEMPERATURE; BLOOD FLOW MODULATION; TUMOR METABOLISM;
D O I
10.1016/0167-8140(94)90010-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have evaluated the influence of tumour temperature on the kinetics and extent of tumour cell death following induction of ischemia. Induction of ischemia in SCCVII tumours implanted subcutaneously in the back of syngeneic C3H mice results in a rapid cooling of the tumour from a resting value of 35.2 degrees C, towards ambient temperature. In the SCCVII tumour no significant cell kill is detected in the first hour of ischemia. At longer times cell kill was detected and a survival level of 2 x 10(-2) was attained after 6 h of ischemia. However, if the tumours were maintained at a temperature of 37 degrees C following induction of ischemia a more rapid and dramatic reduction in cell survival is observed with a survival level of similar to 10(-5) being attained after 4 h of ischemia. Qualitatively similar results are obtained using the Lewis lung tumour implanted in C57BL mice. Similar rapid cooling following occlusion of the blood supply is observed in the C3H/TIF tumour implanted in the foot. For the C3H/TIF induction of ischemia for up to 6 h resulted in no significant growth delay provided the tumours were kept at room temperature. However, if the tumours were maintained at a temperature of 37 degrees C during the ischemic insult significant growth delay was observed for all clamping times exceeding 1 h. These results show the importance of tumour temperature on the kinetics and extent of tumour cell kill during ischemia. This finding has particular relevance for studies in which agents known to reduce tumour blood flow are used in animals bearing superficially located tumours.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 27 条
[1]  
ALGIRE GH, 1951, J NATL CANCER I, V12, P399
[2]  
BARRETT LA, 1977, BEITR PATHOL, V161, P109
[3]   REDUCTION OF TUMOR BLOOD-FLOW BY FLAVONE ACETIC-ACID - A POSSIBLE COMPONENT OF THERAPY [J].
BIBBY, MC ;
DOUBLE, JA ;
LOADMAN, PM ;
DUKE, CV .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (03) :216-222
[4]  
BRAUNSCHWEIGER PG, 1988, CANCER RES, V48, P6011
[5]   RADIOSENSITIZATION INVIVO - A STUDY WITH AN HOMOLOGOUS SERIES OF 2-NITROIMIDAZOLES [J].
CHAPLIN, DJ ;
SHELDON, PW ;
STRATFORD, IJ ;
AHMED, I ;
ADAMS, GE .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1983, 44 (04) :387-398
[7]   THE EFFECT OF HYDRALAZINE ON THE TUMOR-CYTOTOXICITY OF THE HYPOXIC CELL CYTOTOXIN RSU-1069 - EVIDENCE FOR THERAPEUTIC GAIN [J].
CHAPLIN, DJ ;
ACKER, B .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (04) :579-585
[8]   BIOREDUCTIVE THERAPY [J].
CHAPLIN, DJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 22 (04) :685-687
[9]   SOFT AGAR COLONY ASSAY FOR LEWIS LUNG TUMOR AND B16 MELANOMA TAKEN DIRECTLY FROM MOUSE [J].
COURTENAY, VD .
BRITISH JOURNAL OF CANCER, 1976, 34 (01) :39-45
[10]   VASCULAR OCCLUSION AND TUMOR-CELL DEATH [J].
DENEKAMP, J ;
HILL, SA ;
HOBSON, B .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02) :271-275